Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy

BACKGROUND: Emerging evidence suggests that several factors can impact disease progression in transthyretin amyloid polyneuropathy (ATTR-PN). The present analysis used longitudinal data from Val30Met patients participating in the tafamidis (selective TTR stabilizer) clinical development program to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Amass, Leslie, Li, Huihua, Gundapaneni, Balarama K., Schwartz, Jeffrey H., Keohane, Denis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296038/
https://www.ncbi.nlm.nih.gov/pubmed/30558645
http://dx.doi.org/10.1186/s13023-018-0947-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296038/
https://www.ncbi.nlm.nih.gov/pubmed/30558645
http://dx.doi.org/10.1186/s13023-018-0947-7

Ejemplares similares